Impact Capital Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$368K Buy
874
+23
+3% +$9.17K 0.1% 179
2026
Q2
$308K Buy
851
+3
+0.4% +$1.03K 0.08% 206
2026
Q1
$298K Buy
848
+12
+1% +$4.28K 0.09% 221
2025
Q4
$274K Sell
836
-6
-0.7% -$1.9K 0.08% 233
2025
Q3
$238K Sell
842
-17
-2% -$4.93K 0.07% 243
2025
Q2
$240K Sell
859
-78
-8% -$22.1K 0.08% 236
2025
Q1
$292K Buy
937
+39
+4% +$11.5K 0.11% 207
2024
Q4
$234K Hold
898
– – 0.08% 230

Other funds holding AMGN

Impact Capital Partners's AMGN Position: Q3 2026 in Review

Impact Capital Partners increased its Amgen (AMGN) stake by 2.7% in Q3 2026, buying an estimated $9.17K and bringing the position to 874 shares worth $368K. The position accounts for 0.1% of the portfolio, ranked #179.

Impact Capital Partners first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Impact Capital Partners held 874 shares of Amgen worth $368K as of Q3 2026.
  • Impact Capital Partners bought 23 Amgen shares in Q3 2026, an estimated $9.17K.
  • Amgen made up 0.1% of Impact Capital Partners's portfolio in Q3 2026, its #179 holding.
  • Impact Capital Partners first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Impact Capital Partners's 13F filing for Q3 2026, filed 22 Oct 2026.